OTC Product Roundup: Women's Health

Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.

As “therapeutic orphans,” pregnant women and their health care providers must balance the benefits of treatment with the risk of fetal harm.

GoodRx’s new e-commerce service further expands access to Opill by allowing consumers to order the birth control directly to their homes without a prescription.

Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.

With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.

The FDA has approved just the second treatment for uncomplicated urinary tract infections (UTIs) in the last 2 decades.